Mammalian target of rapamycin (mTOR)-related non-infectious pneumonitis: a potential biomarker of clinical benefit?
Rodriguez-Vida, Alejo
Mammalian target of rapamycin (mTOR)-related non-infectious pneumonitis: a potential biomarker of clinical benefit? [electronic resource] - BJU international Mar 2014 - 350-1 p. digital
Publication Type: Editorial; Comment
1464-410X
10.1111/bju.12493 doi
Antineoplastic Agents--adverse effects
Carcinoma, Renal Cell--drug therapy
Everolimus
Female
Humans
Kidney Neoplasms--drug therapy
Male
Pneumonia--chemically induced
Sirolimus--adverse effects
Mammalian target of rapamycin (mTOR)-related non-infectious pneumonitis: a potential biomarker of clinical benefit? [electronic resource] - BJU international Mar 2014 - 350-1 p. digital
Publication Type: Editorial; Comment
1464-410X
10.1111/bju.12493 doi
Antineoplastic Agents--adverse effects
Carcinoma, Renal Cell--drug therapy
Everolimus
Female
Humans
Kidney Neoplasms--drug therapy
Male
Pneumonia--chemically induced
Sirolimus--adverse effects